Preparation, characterization and in vivo evaluation of 2-methoxyestradiol-loaded liposomes

被引:38
作者
Du, Bin [1 ]
Li, Ying [1 ]
Li, Xiaotian [1 ]
Youmei, A. [1 ]
Chen, Chengqun [1 ]
Zhang, Zhenzhong [1 ]
机构
[1] Zhengzhou Univ, Sch Pharm, Zhengzhou 450001, Henan Province, Peoples R China
关键词
2-Methoxyestradiol; Liposomes; Passive target; Tissue distribution; CANCER; NANOPARTICLES; METABOLITE; PROSTATE; PHARMACOKINETICS; STABILITY; EFFICACY; DELIVERY; RELEASE; GROWTH;
D O I
10.1016/j.ijpharm.2009.09.045
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This study systematically investigated the intravenous injection formulation of liposomes loaded with 2-methoxyestradiol (2-ME), a poor water soluble anti-tumor drug. The objective of this study was to design passive targeting nanoliposome which could improve therapeutic efficacy and liver first pass effect. Based on the optimized conditions of single-factor and orthogonal design, 2-ME-loaded liposomes were prepared by the aether injection method. The formulated liposomes were found to be relatively uniform in size with a negative zeta potential. The average drug entrapment efficiency and loading were 85% and 8%, respectively. The overall targeting efficiency (TEC) of the 2-ME-loaded liposomes was enhanced from 40.29% to 88.32% in the lung. The lung damage caused by liposomes was less severe than that by solution. These results indicated that 2-ME liposomes could mainly deliver the drug to the lungs and make the drug accumulate in the lungs, which changed the disposition behavior in vivo, decreased the toxic and side effects on other tissues and reduced the severity of damage to lungs following intravenous injection. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:140 / 147
页数:8
相关论文
共 38 条
[1]  
ANCHALEE AA, 2008, INT J PHARMACEUT, V351, P282
[2]   2-methoxyestradiol arrests cells in mitosis without depolymerizing tubulin [J].
Attalla, H ;
Makela, TP ;
Adlercreutz, H ;
Andersson, LC .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 228 (02) :467-473
[3]   2-methoxyestradiol-induced phosphorylation of Bcl-2:: Uncoupling from JNK/SAPK activation [J].
Attalla, H ;
Westberg, JA ;
Andersson, LC ;
Adlercreutz, H ;
Mäkelä, TP .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 247 (03) :616-619
[4]   PLGA-mPEG nanoparticles of cisplatin: in vitro nanoparticle degradation, in vitro drug release and in Vivo drug residence in blood properties [J].
Avgoustakis, K ;
Beletsi, A ;
Panagi, Z ;
Klepetsanis, P ;
Karydas, AG ;
Ithakissios, DS .
JOURNAL OF CONTROLLED RELEASE, 2002, 79 (1-3) :123-135
[5]   2-methoxyestradiol, an estradiol metabolite, inhibits neointima formation and smooth muscle cell growth via double blockade of the cell cycle [J].
Barchiesi, Federica ;
Jackson, Edwin K. ;
Fingerle, Juergen ;
Gillespie, Delbert G. ;
Odermatt, Bernhard ;
Dubey, Raghvendra K. .
CIRCULATION RESEARCH, 2006, 99 (03) :266-274
[6]   Crosstalk between extrinsic and intrinsic cell death pathways in pancreatic cancer: Synergistic action of estrogen metabolite and ligands of death receptor family [J].
Basu, A ;
Castle, VP ;
Bouziane, M ;
Bhalla, K ;
Haldar, S .
CANCER RESEARCH, 2006, 66 (08) :4309-4318
[7]   SINGLE BILAYER LIPOSOMES PREPARED WITHOUT SONICATION [J].
BATZRI, S ;
KORN, ED .
BIOCHIMICA ET BIOPHYSICA ACTA, 1973, 298 (04) :1015-1019
[8]   BINDING OF ESTRADIOL, PROGESTERONE AND PROLACTIN IN RAT LUNG [J].
BENHARARI, RR ;
AMIT, T ;
YOUDIM, MBH .
JOURNAL OF ENDOCRINOLOGY, 1983, 97 (02) :301-310
[9]   JNK-dependent release of mitochondrial protein, Smac, during apoptosis in multiple myeloma (MM) cells [J].
Chauhan, D ;
Li, GL ;
Hideshima, T ;
Podar, K ;
Mitsiades, C ;
Mitsiades, N ;
Munshi, N ;
Kharbanda, S ;
Anderson, KC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (20) :17593-17596
[10]  
CHONGKOOK K, 1994, INT J PHARMACEUT, V108, P21